Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda

A case–control study from Uganda found that the risk of Kaposi's sarcoma increased with increasing titre of antibodies against Kaposi's sarcoma-associated herpesvirus (KSHV) latent nuclear antigens, independently of HIV infection. Clinically, widespread Kaposi's sarcoma was more frequ...

Descripción completa

Detalles Bibliográficos
Autores principales: Newton, R, Ziegler, J, Bourboulia, D, Casabonne, D, Beral, V, Mbidde, E, Carpenter, L, Parkin, D M, Wabinga, H, Mbulaiteye, S, Jaffe, H, Weiss, R, Boshoff, C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394369/
https://www.ncbi.nlm.nih.gov/pubmed/12888820
http://dx.doi.org/10.1038/sj.bjc.6601113
_version_ 1782155399744454656
author Newton, R
Ziegler, J
Bourboulia, D
Casabonne, D
Beral, V
Mbidde, E
Carpenter, L
Parkin, D M
Wabinga, H
Mbulaiteye, S
Jaffe, H
Weiss, R
Boshoff, C
author_facet Newton, R
Ziegler, J
Bourboulia, D
Casabonne, D
Beral, V
Mbidde, E
Carpenter, L
Parkin, D M
Wabinga, H
Mbulaiteye, S
Jaffe, H
Weiss, R
Boshoff, C
author_sort Newton, R
collection PubMed
description A case–control study from Uganda found that the risk of Kaposi's sarcoma increased with increasing titre of antibodies against Kaposi's sarcoma-associated herpesvirus (KSHV) latent nuclear antigens, independently of HIV infection. Clinically, widespread Kaposi's sarcoma was more frequent among patients with HIV infection than in those without, but was not related to anti-KSHV antibody titres.
format Text
id pubmed-2394369
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23943692009-09-10 Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda Newton, R Ziegler, J Bourboulia, D Casabonne, D Beral, V Mbidde, E Carpenter, L Parkin, D M Wabinga, H Mbulaiteye, S Jaffe, H Weiss, R Boshoff, C Br J Cancer Epidemiology A case–control study from Uganda found that the risk of Kaposi's sarcoma increased with increasing titre of antibodies against Kaposi's sarcoma-associated herpesvirus (KSHV) latent nuclear antigens, independently of HIV infection. Clinically, widespread Kaposi's sarcoma was more frequent among patients with HIV infection than in those without, but was not related to anti-KSHV antibody titres. Nature Publishing Group 2003-08-04 2003-07-29 /pmc/articles/PMC2394369/ /pubmed/12888820 http://dx.doi.org/10.1038/sj.bjc.6601113 Text en Copyright © 2003 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Epidemiology
Newton, R
Ziegler, J
Bourboulia, D
Casabonne, D
Beral, V
Mbidde, E
Carpenter, L
Parkin, D M
Wabinga, H
Mbulaiteye, S
Jaffe, H
Weiss, R
Boshoff, C
Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda
title Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda
title_full Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda
title_fullStr Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda
title_full_unstemmed Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda
title_short Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda
title_sort infection with kaposi's sarcoma-associated herpesvirus (kshv) and human immunodeficiency virus (hiv) in relation to the risk and clinical presentation of kaposi's sarcoma in uganda
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394369/
https://www.ncbi.nlm.nih.gov/pubmed/12888820
http://dx.doi.org/10.1038/sj.bjc.6601113
work_keys_str_mv AT newtonr infectionwithkaposissarcomaassociatedherpesviruskshvandhumanimmunodeficiencyvirushivinrelationtotheriskandclinicalpresentationofkaposissarcomainuganda
AT zieglerj infectionwithkaposissarcomaassociatedherpesviruskshvandhumanimmunodeficiencyvirushivinrelationtotheriskandclinicalpresentationofkaposissarcomainuganda
AT bourbouliad infectionwithkaposissarcomaassociatedherpesviruskshvandhumanimmunodeficiencyvirushivinrelationtotheriskandclinicalpresentationofkaposissarcomainuganda
AT casabonned infectionwithkaposissarcomaassociatedherpesviruskshvandhumanimmunodeficiencyvirushivinrelationtotheriskandclinicalpresentationofkaposissarcomainuganda
AT beralv infectionwithkaposissarcomaassociatedherpesviruskshvandhumanimmunodeficiencyvirushivinrelationtotheriskandclinicalpresentationofkaposissarcomainuganda
AT mbiddee infectionwithkaposissarcomaassociatedherpesviruskshvandhumanimmunodeficiencyvirushivinrelationtotheriskandclinicalpresentationofkaposissarcomainuganda
AT carpenterl infectionwithkaposissarcomaassociatedherpesviruskshvandhumanimmunodeficiencyvirushivinrelationtotheriskandclinicalpresentationofkaposissarcomainuganda
AT parkindm infectionwithkaposissarcomaassociatedherpesviruskshvandhumanimmunodeficiencyvirushivinrelationtotheriskandclinicalpresentationofkaposissarcomainuganda
AT wabingah infectionwithkaposissarcomaassociatedherpesviruskshvandhumanimmunodeficiencyvirushivinrelationtotheriskandclinicalpresentationofkaposissarcomainuganda
AT mbulaiteyes infectionwithkaposissarcomaassociatedherpesviruskshvandhumanimmunodeficiencyvirushivinrelationtotheriskandclinicalpresentationofkaposissarcomainuganda
AT jaffeh infectionwithkaposissarcomaassociatedherpesviruskshvandhumanimmunodeficiencyvirushivinrelationtotheriskandclinicalpresentationofkaposissarcomainuganda
AT weissr infectionwithkaposissarcomaassociatedherpesviruskshvandhumanimmunodeficiencyvirushivinrelationtotheriskandclinicalpresentationofkaposissarcomainuganda
AT boshoffc infectionwithkaposissarcomaassociatedherpesviruskshvandhumanimmunodeficiencyvirushivinrelationtotheriskandclinicalpresentationofkaposissarcomainuganda
AT infectionwithkaposissarcomaassociatedherpesviruskshvandhumanimmunodeficiencyvirushivinrelationtotheriskandclinicalpresentationofkaposissarcomainuganda

Ejemplares similares